502.717.4080 Moore Law Group, PLLC, 1473 South 4th Street, Louisville, KY 40208  
 
Firm Overview
Practice Areas
Car Accidents
Truck Accidents
Motorcycle Accidents
Brain Injury
Medical Negligence
Defective Products
Birth Trauma
Medical Devices
Our Attorneys
Jennifer A Moore
Emily A DeVuono
Ashton Rose Smith
Videos
Links
Defective Products
Need Our Help?
Your Full Name:

Your Phone Number:

Your Email Address:

Tell Us About Your Issue:


Please Enter This Code:
Code for Spam Protection  



Full Contact Form
Actos Diabetes Medication FDA Warning
In 2011, the FDA advised that use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer. Information about this risk was added to the *Warnings and Precautions* section of the label for pioglitazone-containing medicines. The patient Medication Guide for these medicines were also revised to include information on the risk of bladder cancer.

Safety information is based on FDA's review of data from a five-year interim analysis of an ongoing, ten-year epidemiological study, was described in FDA's September 2010 ongoing safety review.

In a recent study published in the British Medical Journal, the authors conclude that "(t)he use of pioglitazone is associated with an increased risk of incident bladder cancer among people with type 2 diabetes.” This is a serious health risk.

If you have developed bladder cancer following use of Actos, you or your family may be eligible for compensation. Lawsuits have been filed involving this product. If you may have been harmed by this product, it is in your best interest to act now.

For more information about Pioglitazone (marketed as Actos, Actoplus Met, and Duetact) the following is available from the FDA: FDA Information.

Contact us to discuss your potential claim today.